Guran T, Kara C, Yildiz M, Bitkin EC, Haklar G, Lin JC, Keskin M, Barnard L, Anik A, Catli G, Guven A, Kirel B, Tutunculer F, Onal H, Turan S, Akcay T, Atay Z, Yilmaz GC, Mamadova J, Akbarzade A, Sirikci O, Storbeck KH, Baris T, Chung BC, Bereket A.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgaa022. doi: 10.1210/clinem/dgaa022.
PMID:31950145
Genotype, Mortality, Morbidity, and Outcomes of 3beta-Hydroxysteroid Dehydrogenase Deficiency in Algeria.
Ladjouze A, Donaldson M, Plotton I, Djenane N, Mohammedi K, Tardy-Guidollet V, Mallet D, Boulesnane K, Bouzerar Z, Morel Y, Roucher-Boulez F.
Front Endocrinol (Lausanne). 2022 Jun 10;13:867073. doi: 10.3389/fendo.2022.867073. eCollection 2022.
PMID:35757411
Diagnostic and therapeutic pitfalls in the management of pediatric patients with 3β-hydroxysteroid dehydrogenase type 2 (3β-HSD2) deficiency - a single center experience.
Gawlik Z, Preizner-Rzucidło E, Kaleta K, Szwarkowska M, Wróblewska M, Jurek A, Książek T, Jażdżewski K, Siejka A, Starzyk J, Januś D.
Front Endocrinol (Lausanne). 2025 Sep 25;16:1642051. doi: 10.3389/fendo.2025.1642051. eCollection 2025.
PMID:41079182
A new insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency.
Simard J, Ricketts ML, Moisan AM, Tardy V, Peter M, Van Vliet G, Morel Y.